Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Dr. Eugenio Greco,
Decrease in early mortality in STEMI attributed to changing patient profile and behaviour, and improved organisation of care: Data from four French registries over 15 years. European Society of Cardiology Congress; Munich, Germany: 25–29 August 2012Press Release l SessionN. Danchin et al.
The results of this French study, presented by N. Danchin at the ESC Congress 2012 in Munich, showed a decrease by 68%, from 13.7% to 4.4%, in early mortality in STEMI (ST-elevation myocardial infarction) patients. Around one quarter of this mortality reduction could be attributed to a change in patient characteristics and improved organisation of care.The study data was processed from four French nationwide registries of STEMI patients (French registries USIK 1995, USIC 2000, FAST-MI 2005 and FAST-MI 2010), covering more than 15 years.The analysis did indeed show a notable change in population characteristics and improved organisation of care:
N. Danchin concluded that:“... Spectacular progress has been made in the treatment of ST-elevation myocardial infarction, and most of this progress is generally attributed to the more frequent administration of reperfusion therapy, particularly by primary PCI... [but]... the major decline in early mortality for STEMI patients should not be attributed only to improved delivery of reperfusion treatment. The improvement also reflects a profound and preoccupying change in the type of patient having a heart attack, with a particular increase in the number of young women. This increase is concomitant with an increased prevalence of smoking and obesity".
© 2017 European Society of Cardiology. All rights reserved